Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
67
TRMK Quote, Financials, Valuation and Earnings
Last price:
$38.27
Seasonality move
:
1.61%
Day range:
$37.14 - $38.28
52-week range:
$29.77 - $40.73
Dividend yield:
2.47%
P/E ratio:
9.90x
P/S ratio:
4.89x
P/B ratio:
1.14x
Volume:
256.2K
Avg. volume:
308.8K
1-year change:
13.37%
Market cap:
$2.3B
Revenue:
$455.5M
EPS (TTM):
$3.84
Analysts' Opinion
-
Consensus RatingTrustmark has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $42.70, Trustmark has an estimated upside of 12.37% from its current price of $38.00.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $39.00 representing 100% downside risk from its current price of $38.00.
Fair Value
-
According to the consensus of 5 analysts, Trustmark has 12.37% upside to fair value with a price target of $42.70 per share.
TRMK vs. S&P 500
-
Over the past 5 trading days, Trustmark has underperformed the S&P 500 by -1.39% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Trustmark does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Trustmark has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Trustmark reported revenues of $167.7M.
Earnings Growth
-
Trustmark has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Trustmark reported earnings per share of $0.88.
Enterprise value:
2.3B
EV / Invested capital:
--
Price / LTM sales:
4.89x
EV / EBIT:
5.53x
EV / Revenue:
4.76x
PEG ratio (5yr expected):
0.20x
EV / Free cash flow:
9.77x
Price / Operating cash flow:
10.04x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
1.28%
Net Income Margin (TTM):
49.34%
Return On Equity:
12.34%
Return On Invested Capital:
9.54%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $573.2M | $588M | $476.6M | $146.6M | $167.7M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $1.51 | $2.57 | $3.84 | $0.68 | $0.88 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.1B | $4.9B | $3.3B | $2.3B | $620.4M | |
| Total Assets | $16.9B | $17.4B | $18.9B | $18.4B | $18.3B | |
| Current Liabilities | $161M | $170.5M | $478M | $393.2M | $360.1M | |
| Total Liabilities | $15.1B | $15.8B | $17.3B | $16.7B | $16.3B | |
| Total Equity | $1.8B | $1.6B | $1.6B | $1.7B | $2B | |
| Total Debt | $330.7M | $269.6M | $1.7B | $667.4M | $590.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $237.2M | $135.8M | $257.9M | -$58.5M | $82.4M | |
| Cash From Investing | -$2.2B | -$213.2M | $192.3M | -$51.3M | -$143.6M | |
| Cash From Financing | $1.3B | -$613.5M | -$468.9M | -$259.4M | $81.3M | |
| Free Cash Flow | $191.2M | $99.8M | $232.1M | -$65.6M | $78.1M | |
TRMK
Sector
Market Cap
$2.3B
$627.9M
Price % of 52-Week High
93.3%
89.42%
Dividend Yield
2.47%
1.97%
Shareholder Yield
--
4.06%
1-Year Price Total Return
13.37%
7.77%
Beta (5-Year)
0.664
0.585
Dividend yield:
2.47%
Annualized payout:
$0.92
Payout ratio:
24.38%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$38.30
200-day SMA
Buy
Level
$35.40
Bollinger Bands (100)
Buy
Level
33.1 - 36.7
Chaikin Money Flow
Buy
Level
72.2K
20-day SMA
Buy
Level
$36.88
Relative Strength Index (RSI14)
Buy
Level
60.37
ADX Line
Sell
Level
15.63
Williams %R
Neutral
Level
-27.4788
50-day SMA
Buy
Level
$35.75
MACD (12, 26)
Buy
Level
10.42
25-day Aroon Oscillator
Buy
Level
56
On Balance Volume
Neutral
Level
753.1K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.4457)
Sell
CA Score
(Annual)
Level (-2.2004)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (1.5447)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.
Stock Forecast FAQ
In the current month, TRMK has received 1 Buy ratings 4 Hold ratings, and 0 Sell ratings. The TRMK average analyst price target in the past 3 months is $42.70.
-
Where Will Trustmark Stock Be In 1 Year?
According to analysts, the consensus estimate is that Trustmark share price will rise to $42.70 per share over the next 12 months.
-
What Do Analysts Say About Trustmark?
Analysts are divided on their view about Trustmark share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Trustmark is a Sell and believe this share price will drop from its current level to $39.00.
-
What Is Trustmark's Price Target?
The price target for Trustmark over the next 1-year time period is forecast to be $42.70 according to 5 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is TRMK A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Trustmark is a Hold. 4 of 5 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of TRMK?
You can purchase shares of Trustmark via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Trustmark shares.
-
What Is The Trustmark Share Price Today?
Trustmark was last trading at $38.27 per share. This represents the most recent stock quote for Trustmark. Yesterday, Trustmark closed at $38.00 per share.
-
How To Buy Trustmark Stock Online?
In order to purchase Trustmark stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
93
EXOD alert for Jul 18
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
